142 related articles for article (PubMed ID: 18783684)
1. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.
Rodríguez-Moranta F; Trapero-Bertran M; Castells A; Mas-Canal X; Balaguer F; Pellisé M; Gonzalo V; Ocaña T; Trilla A; Piqué JM
Gastroenterol Hepatol; 2008; 31(7):405-12. PubMed ID: 18783684
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
6. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
10. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.
Ventura L; Zappa M; Carreras G; Ciatto S; Grazzini G
Tumori; 2011; 97(5):547-50. PubMed ID: 22158481
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
12. Participation in colorectal cancer screening: a review.
Vernon SW
J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
[TBL] [Abstract][Full Text] [Related]
13. The impact of colorectal cancer screening on life expectancy.
Inadomi JM; Sonnenberg A
Gastrointest Endosc; 2000 May; 51(5):517-23. PubMed ID: 10805834
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
15. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.
Zauber AG; Lansdorp-Vogelaar I; Knudsen AB; Wilschut J; van Ballegooijen M; Kuntz KM
Ann Intern Med; 2008 Nov; 149(9):659-69. PubMed ID: 18838717
[TBL] [Abstract][Full Text] [Related]
16. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
Song K; Fendrick AM; Ladabaum U
Gastroenterology; 2004 May; 126(5):1270-9. PubMed ID: 15131787
[TBL] [Abstract][Full Text] [Related]
17. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA
Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
